abagovomab 26
abciximab 24
abituzumab 21
abrilumab 18
actoxumab 13
adalimumab 17
aducanumab 11
afasevikumab 15
alacizumab_pegol 11
alemtuzumab 22
alirocumab 21
amatuximab 35
andecaliximab 22
anifrolumab 18
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 18
ascrinvacumab 4
atezolizumab 16
atinumab 16
avelumab 12
basiliximab 24
bavituximab 32
begelomab 21
benralizumab 23
bevacizumab_beta 19
bezlotoxumab 13
bimagrumab 11
bleselumab 12
blinatumomab 26
blosozumab 28
bococizumab 17
brazikumab 18
brentuximab_vedotin 32
briakinumab 19
brodalumab 7
brolucizumab 26
brontictuzumab 25
burosumab 17
cabiralizumab 25
camrelizumab 14
canakinumab 23
cantuzumab_ravtansin 37
carlumab 13
carotuximab 24
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 25
cetiximab 39
citatuzumab_bogatox 25
cixutumumab 23
clivatuzumab_tetraxetan 14
codrituzumab 28
conatumumab 11
concizumab 28
crenezumab 19
crizanlizumab 26
crotedumab 21
dacetuzumab 21
daclizumab 13
dalotuzumab 30
dapirolizumab_pegol 23
daratumumab 13
dectrekumab 10
demcizumab 21
denosumab 8
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 19
dinutuximab 30
diridavumab 18
domagrozumab 17
drozitumab 14
duligotuzumab 20
durvalumab 8
dusigitumab 14
efalizumab 33
efungumab 27
eldelumab 16
elezanumab 20
elgemtumab 12
elotuzumab 14
emactuzumab 15
emapalumab 25
emibetuzumab 14
enavatuzumab 24
enfortumab_vedotin 14
enoblituzumab 17
enokizumab 25
enoticumab 19
ensituximab 26
eptinezumab 16
erenumab 19
etaracizumab 15
etrolizumab 22
evinacumab 22
evolocumab 15
farletuzumab 3
fasinumab 20
fezakinumab 19
fibatuzumab 10
ficlatuzumab 20
firivumab 28
flanvotumab 16
fletikumab 14
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 16
ganitumab 20
gantenerumab 12
gemetuzumab 22
gemtuzumab2 24
gemtuzumab 22
gevokizumab 21
girentuximab 27
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 26
ibritumomab 26
icrucumab 11
idarucizumab 29
ifabotuzumab 10
imalumab 18
imgatuzumab 19
inclacumab 21
indatuximab_ravtansin 26
indusatumab 14
inebilizumab 22
intetumumab 12
iodine_girentuximab 28
ipilimumab 7
iratumumab 7
isatuximab 31
itolizumab 22
ixekizumab 30
labetuzumab_govitecan 19
lambrolizumab 23
lampalizumab 21
lanadelumab 18
landogrozumab 18
laprituximab 26
lebrikizumab 32
lendalizumab 23
lenzilumab 16
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 32
lirilumab 24
lodelcizumab 16
lokivetmab 25
lorvotuzumab_mertansin 22
lucatumumab 30
lumretuzumab 17
lupartumab 15
lutikizumab 18
margetuximab 30
milatuzumab 36
mirvetuximab 28
mirvetuximab_soravtansin 28
modotuximab 36
mogamulizumab 28
monalizumab 17
motavizumab 31
moxetumomab_pasudotox 23
namilumab 20
naratuximab 27
naratuximab_emtansin 27
narnatumab 16
navicixizumab2 26
navicixizumab 23
navivumab 33
necitumumab 10
nemolizumab 22
nesvacumab 16
nivolumab 12
obiltoxaximab 19
obinutuzumab 31
ocaratuzumab 21
ofatumumab 19
olaratumab 18
olokizumab 23
omalizumab 19
onartuzumab 21
ontuxizumab 21
opicinumab 13
orticumab 13
otelixizumab 35
oxelumab 13
ozanezumab 30
pamrevlumab 13
panobacumab 23
parsatuzumab 24
pasotuxizumab 22
pateclizumab 16
patritumab 16
pembrolizumab 23
perakizumab 23
pidilizumab 14
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 20
polatuzumab_vedotin 22
ponezumab 32
prezalumab 15
pritoxaximab 33
quilizumab 21
racotumomab 27
radretumab 14
ralpancizumab 22
ramucirumab 13
ranevetmab 25
ranibizumab 19
refanezumab 21
remtolumab 19
rilotumumab 14
rinucumab 15
risankizumab 29
rituximab 17
rivabazumab 22
robatumumab 20
roledumab 31
romosozumab 17
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 21
sacituzumab 26
sacituzumab_govitecan 26
samalizumab 26
sapelizumab 23
sarilumab 17
secukinumab 12
seribantumab 16
setoxaximab 37
sifalimumab 9
siltuximab 17
simtuzumab 25
sirukumab 12
solanezumab 27
solitomab 23
stamulumab 16
suptavumab 22
suvizumab 19
tabalumab 11
tadocizumab 12
tamtuvetmab 30
tanezumab 20
tarextumab 11
tavolixizumab 13
telisotuzumab 24
teplizumab 16
tesidolumab 20
tezepelumab 25
tigatuzumab 15
tildrakizumab 21
timolumab 14
tisotumab 11
tosatoxumab 30
tositumomab 23
tralokinumab 21
trastuzumab 24
tregalizumab 22
trevogrumab 11
ublituximab 26
urelumab 17
ustekinumab 27
utomilumab 26
vadastuximab 20
vadastuximab_talirin 20
vandortuzumab_vedotin 16
vantictumab 19
vanucizumab2 19
vanucizumab 27
varlilumab 16
vatelizumab 17
vedolizumab 23
veltuzumab 13
vesencumab 10
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 27
xentuzumab 17
zatuximab 36
